Establish Clear Clinical Criteria for Coverage Approving GLP-1s for every employee who requests them is not financially sustainable
Beyond working with a doctor to ensure nutritional benchmarks are met, the recommendations include screening for a history of disordered eating and taking into account a persons whole health before prescribing
Do not exceed the recommended dose, as long-term or excessive use of Carni-Q Tablet may cause unwanted effects
In particular: CVS Caremark has stopped covering Zepbound, an Eli Lilly GLP-1 drug that is approved for long-term weight control
Support the System: Eat a nutrient-dense diet to provide necessary co-factors
And if you are curious about newer options on the horizon, the comparison between semaglutide, tirzepatide, and retatrutide gives you a sense of where the field is heading and what future combinations might look like